59 related articles for article (PubMed ID: 11576461)
41. An early effect of acute plasma volume expansion in humans on serum erythropoietin concentration.
Szyguła Z; Smitz J; Roeykens J; De Meirleir K; Klausen T
Eur J Appl Physiol Occup Physiol; 1995; 72(1-2):106-10. PubMed ID: 8789579
[TBL] [Abstract][Full Text] [Related]
42. Interferon-alpha does not cause significant cardiac dysfunction in patients with chronic active hepatitis.
Kadayifci A; Aytemir K; Arslan M; Aksoyek S; Sivri B; Kabakci G
Liver; 1997 Apr; 17(2):99-102. PubMed ID: 9138280
[TBL] [Abstract][Full Text] [Related]
43. Regulation of plasma erythropoietin in chronic liver disease.
Tacke F; Luedde T; Manns MP; Trautwein C
World J Gastroenterol; 2004 Oct; 10(19):2922-3. PubMed ID: 15334703
[No Abstract] [Full Text] [Related]
44. The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein.
Xie H; Song J; Liu K; Ji H; Shen H; Hu S; Yang G; Du Y; Zou X; Jin H; Yan L; Liu J; Fan D
Dig Dis Sci; 2008 Dec; 53(12):3225-33. PubMed ID: 18465238
[TBL] [Abstract][Full Text] [Related]
45. Physiology and pathophysiology of pleural fluid turnover.
Miserocchi G
Eur Respir J; 1997 Jan; 10(1):219-25. PubMed ID: 9032518
[TBL] [Abstract][Full Text] [Related]
46. Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases.
Bruno CM; Neri S; Sciacca C; Bertino G; Di Prima P; Cilio D; Pellicano R; Caruso L; Cristaldi R
World J Gastroenterol; 2004 May; 10(9):1353-6. PubMed ID: 15112358
[TBL] [Abstract][Full Text] [Related]
47. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
48. Interferon treatment in children with chronic hepatitis B: an Israeli experience.
Hartman C; Hager H; Berkowitz D; Rimon N; Bassan L; Trogouboff P; Teitler A; Shamir R
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):914-8. PubMed ID: 12455179
[TBL] [Abstract][Full Text] [Related]
49. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.
Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P
Acta Virol; 2001; 45(5-6):293-7. PubMed ID: 12083328
[TBL] [Abstract][Full Text] [Related]
51. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
52. Influence of IFN-alpha on plasma erythropoietin levels in patients with hepatitis B virus-associated chronic active hepatitis.
Oczko-Grzesik B; Wiecek A; Kokot F
J Interferon Cytokine Res; 2001 Sep; 21(9):669-76. PubMed ID: 11576461
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
